International Harmonization of MRD in Myeloma
Advances in multiple myeloma (MM) therapies have enhanced the likelihood of achieving deeper treatment responses which in turn carry significant prognostic implications.
RNA editing as diversifier of genetic information in Leukemia
Implications of RNA editing on chronic lymphocytic leukemia
Toward the era of Quantitative Diagnostics
QDB, the only platform to achieve absolute quantitation of protein biomarkers in FFPE samples to meet the daily clinical need